Clinical Trial Update: Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is testing daily temozolomide in elderly patients with newly diagnosed glioblastoma and unmethylated MGMT promoter; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Glioblastoma | Phase 2 | Status: RECRUITING